Ivanhoe Mines Ltd. (TSE:IVN – Get Free Report) has earned a consensus recommendation of “Buy” from the eight ratings firms that are currently covering the company, MarketBeat Ratings reports. Eight investment analysts have rated the stock with a buy recommendation. The average 1 year target price among analysts that have issued a report on the stock in the last year is C$24.30.
Several brokerages have recently commented on IVN. Royal Bank of Canada lowered their target price on shares of Ivanhoe Mines from C$25.00 to C$24.00 and set an “outperform” rating on the stock in a report on Tuesday, September 10th. Scotiabank increased their price target on shares of Ivanhoe Mines from C$21.00 to C$22.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th.
Read Our Latest Research Report on IVN
Insider Transactions at Ivanhoe Mines
Ivanhoe Mines Stock Performance
The company has a debt-to-equity ratio of 4.24, a quick ratio of 20.86 and a current ratio of 1.17. The company has a 50-day simple moving average of C$19.05 and a 200-day simple moving average of C$18.37. Ivanhoe Mines has a 52-week low of C$12.51 and a 52-week high of C$21.32. The company has a market capitalization of C$24.48 billion, a PE ratio of 113.31 and a beta of 1.94.
About Ivanhoe Mines
Ivanhoe Mines Ltd. engages in the mining, development, and exploration of minerals and precious metals primarily in Africa. It explores for platinum, palladium, nickel, copper, gold, rhodium, zinc, silver, germanium, and lead deposits. The company's projects include the Platreef project located in the Northern Limb of South Africa's Bushveld Complex; the Kipushi project located in Haut-Katanga Province, Democratic Republic of Congo; and the Kamoa-Kakula project located within the Central African Copperbelt.
Read More
- Five stocks we like better than Ivanhoe Mines
- What Are the FAANG Stocks and Are They Good Investments?
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- 3 Healthcare Dividend Stocks to Buy
- Texas Instruments: The Old-School Tech Titan Still Delivering
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for Ivanhoe Mines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ivanhoe Mines and related companies with MarketBeat.com's FREE daily email newsletter.